Category Archives: Press Release

Portage’s Biohaven Orphan Drug Designation Request Granted for the Treatment of Spinocerebellar Ataxia

...

Portage’s Biohaven Announces Expedited Development Path for BHV-0223 Following Successful Pre-IND Interaction with FDA

...

Portage’s Biohaven Announces Positive Results from Phase I Study with BHV-0223

...

Mr. James Mellon and Dr. Gregory Bailey (“Offerors”) Announce Additional Shares in Portage Biotech Inc.

...

Portage’s Biohaven Announce Phase I Pharmacokinetic Study Meets Study Objectives and Supports Advancing BHV-0223 and also Appoints a CEO

...

Portage’s Biohaven Completes Multiple Dose Phase of Pharmacokinetic Trial with BHV-0223

...

Biohaven and Fox Chase Chemical Diversity Center Announce Strategic Alliance in Early Stage Drug Discovery Research

...

Portage’s Biohaven Completes Single Dose Phase of Pharmacokinetic Trial with BHV-0223

...

Portage’s PPL Will Advance its Lead Candidate PPL-003 to an IND for Dry Eye Disease and Uveitis

...

Portage’s Biohaven Doses First Human Subject in Phase I Trial with Lead Drug Candidate BHV-0223

...